topic

1325 Bariatric surgery-induced modulation of gut microbiota improves response to αPD-1 immunotherapy in preclinical model of breast cancer after bariatric surgery
Margaret S Bohm, Laura M Sipe, Sydney C Joseph, Boston W Simmons, Madeline E Pye, Ashley M Sidebottom, Eugene B Chang, Joseph F Pierre, Liza Makowski

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1476; DOI: 10.1136/jitc-2023-SITC2023.1325
1326 Modulation of the gut microbiota drives microbial translocation to the tumor microenvironment in melanoma
Alex C McPherson, Catherine Phelps, Mackenzie Bender, Colin Laughlin, Marlies Meisel

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1477; DOI: 10.1136/jitc-2023-SITC2023.1326
1327 Gut microbiota and its metabolites are important determinants of the immune response to the MUC1 vaccine in the setting of colon cancer prevention
Amir Hossein Mohseni, Sedigheh Taghinezhadsaroukalaei, Pamela Beatty, Olivera J Finn

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1478; DOI: 10.1136/jitc-2023-SITC2023.1327
1328 The use of fecal filtrate transplant to enhance response to immune checkpoint blockade
Golnaz Morad, Sarah Johnson, Manoj Chelvanambi, Matthew Wong, Ashish Damania, Nadim Ajami, Jennifer Wargo

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1479; DOI: 10.1136/jitc-2023-SITC2023.1328
1329 The use of novel microbial-based therapeutics in the treatment of cancer
Alicia Nicklin, Christopher Price, Luke Mitchell, Anne Jordan, Mitch Rowe, Lindsay Hall, Stephen Robinson

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1480; DOI: 10.1136/jitc-2023-SITC2023.1329
1330 Gut microbiome dysbiosis promotes immune suppression and lung cancer development
Zahraa Rahal, Yuejiang Liu, Fuduan Peng, Matthew Ross, Ansam Sinjab, Ke Liang, Jiping Feng, Chidera Chukwuocha, Manvi Sharma, Elizabeth Tang, Camille Abaya, Joseph Petrosino, Junya Fujimoto, Seyed Javad Moghaddam, Linghua Wang, Kristi Hoffman, Humam Kadara

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1481; DOI: 10.1136/jitc-2023-SITC2023.1330
1331 Cancer vaccine development based on molecular mimicry
Maria Tagliamonte, Concetta Ragone, Beatrice Cavalluzzo, Angela Mauriello, Luigi Buonaguro

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1482; DOI: 10.1136/jitc-2023-SITC2023.1331
1332 rHSA-CORMs: a CO-based approach in cancer immunotherapy
Carlos Almeida, Gonçalo Bernardes

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1483; DOI: 10.1136/jitc-2023-SITC2023.1332
1333 FG-3165 is a novel galectin-9 neutralizing antibody that inhibits galectin-9-mediated dimerization of TIM-3 and galectin-9-induced apoptosis of CD4⁺ and CD8⁺ T cells
Prachi Bagadia, Selene Li, Mitch Brenner, Veronica Rodriguez, Mark Sternlicht, Todd Seeley, John Hunter, Dave Olsen, Gail Walkinshaw

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1484; DOI: 10.1136/jitc-2023-SITC2023.1333
1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors
Arnima Bisht, Chander Peddaboina, Chantia Carroll, Harald Haeske, Christian Rohlff

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1485; DOI: 10.1136/jitc-2023-SITC2023.1334

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages